Business expansion in South Carolina
Encompass Health (EHC) has opened the Encompass Health Rehabilitation Hospital of Irmo, a 49 bed inpatient facility in South Carolina, expanding its regional rehabilitation footprint and adding capacity across several complex care needs.
See our latest analysis for Encompass Health.
Against this backdrop, Encompass Health’s 1 year total shareholder return of 8.6% and 3 year total shareholder return of around 7x, alongside a modest year to date share price gain of 0.6%, suggest longer term momentum has been stronger than recent trading implies.
If this expansion has you thinking about where else growth stories might be emerging, it could be a good time to scan our 32 healthcare AI stocks as another way to spot potential opportunities in care related technologies.
With annual revenue of US$5.94b, net income of US$565.7m and a value score of 6, plus a modelled intrinsic value that is 26% above the current price, is Encompass Health underappreciated or already pricing in future growth?
Most Popular Narrative: 25.1% Undervalued
With Encompass Health last closing at $106.95 against a narrative fair value of $142.73, the current price sits well below that benchmark, which raises a clear question about what assumptions are driving that gap.
The surge in the 65 plus population and persistent undersupply of inpatient rehabilitation beds are driving high and still unmet demand for Encompass Health's core services, ongoing hospital openings and bed expansions position the company to capture significant incremental patient volume, supporting higher revenue growth for years to come.
Want to see how this demand story feeds into revenue, margins, and the final fair value line? The key assumptions on growth, profitability and future earnings multiples are all laid out in the full narrative, but the exact mix and pacing of those inputs may surprise you.
Result: Fair Value of $142.73 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, that story depends on tight execution. Ongoing labor shortages and heavy hospital build costs are both capable of pressuring margins and tempering the current valuation case.
Find out about the key risks to this Encompass Health narrative.
Next Steps
If this mix of enthusiasm and caution around Encompass Health resonates with you, it may be helpful to quickly review the full picture so you can weigh the 5 key rewards and 2 important warning signs for yourself.
Looking for more investment ideas?
If Encompass Health is already on your radar, do not stop there. The next idea in your portfolio could be sitting just a quick screen away.
- Expand your watchlist with companies our tools flag as potential value opportunities using the 50 high quality undervalued stocks built from fundamental data.
- Strengthen your income stream by checking out the 16 dividend fortresses that focuses on businesses offering higher yields with support from their underlying metrics.
- Reduce portfolio stress by scanning the 64 resilient stocks with low risk scores which highlights companies assessed to have more resilient risk profiles.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com